Literature DB >> 10569529

Tissue biocompatibility of a new caprolactone-coated self-reinforced self-expandable poly-L-lactic acid bioabsorbable urethral stent.

T Isotalo1, A Halasz, M Talja, T L Tammela, S Paasimaa, P Törmälä.   

Abstract

BACKGROUND AND
PURPOSE: The bioabsorption time as well as other properties of bioabsorbable polymers can be affected by the choice of the basic molecule, by the degree of its polymerization, and by the coating material used in the device. The aim of our present study was to evaluate the biocompatibility of a new caprolactone copolymer-coated, self-reinforced poly-L-lactic acid (SR-PLLA) urethral stent by means of a rabbit muscle implantation test. This new material has previously been tested for cytotoxicity using the thymidine incorporation method (DNA synthesis inhibition test), no toxicity being evidenced.
MATERIALS AND METHODS: Fifteen male rabbits were used as experimental animals. Rods made from pure lactic acid, pure caprolactone copolymer, and caprolactone-coated lactic acid were placed on both sides of the dorsal muscles, eight implants per rabbit. Rods made from latex and silicone were used as positive and negative controls, respectively. The animals were sacrificed after 1 week, 1 month, or 6 months. Tissue reactions around the implants were analyzed and scored semiquantitatively.
RESULTS: Acute tissue reactions attributable to operative trauma were seen in all specimens at 1 week. After 6 months, chronic inflammatory changes and foreign-body reactions were seen only in the positive controls.
CONCLUSION: The new caprolactone copolymer material is highly biocompatible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569529     DOI: 10.1089/end.1999.13.525

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  1 in total

1.  Tissue biocompatibility of new biodegradable drug-eluting stent materials.

Authors:  Ilkka Uurto; Andres Kotsar; Taina Isotalo; Joonas Mikkonen; Paula M Martikainen; Minna Kellomäki; Pertti Törmälä; Teuvo L J Tammela; Martti Talja; Juha-Pekka Salenius
Journal:  J Mater Sci Mater Med       Date:  2007-04-17       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.